Kizoo invests in never-done-before technologies in rejuvenation biotech, targeting global impact on extending healthy lifespans. Focuses on addressing root causes of aging (e.g., cellular waste, calcification, mitochondrial dysfunction) via novel drug compounds, therapeutics, and stem cell rejuvenation. Historically backed Germany’s internet/SaaS unicorns but no new investments in this sector.
Preferred startup development maturity for initial funding deployment.
Emerging technologies in rejuvenation biotech and internet/SaaS (historical investments only in SaaS)
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...